BeiGene, Ltd. (BGNE) PT Raised to $295 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BGNE Hot Sheet
Price: $148.56 +3.08%
Rating Summary:
16 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
16 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $295.00 (from $290.00) while maintaining a Overweight rating.
You May Also Be Interested In
- MarineMax (HZO) PT Lowered to $35 at Stifel
- Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
- First Cash Financial (FCFS) PT Lowered to $140 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
